Genitourinary Cancer
Conference Coverage
High-dose RT and long-term ADT improve survival in high-risk prostate cancer
These results are “practice-affirming for many,” according to an expert commenting on the new findings.
News
Dana-Farber Moves to Retract, Correct Dozens of Cancer Papers Amid Allegations
Dana-Farber Cancer Institute retracts six papers and corrects more than 30 after data changes found.
News
Functional Outcomes in Localized Prostate Cancer: Treatment Choice, Time, Prognosis All Matter
New study sheds light on quality of life effects related to disease severity and treatment choice.
News
Prostate Risks Similar for Testosterone Therapy and Placebo
Uncertainty and concern exist about a link between prostate cancer risk and testosterone levels.
News
Radiation Oncologists Fight for Payment Reform Amid Cuts
Over the past decade, radiation oncologists have seen a 23% drop in Medicare reimbursement for...
News
CMS Okays Payment for Novel AI Prostate Test
The test improves risk stratification or prognostication over standard clinical and pathologic tools, says expert.
News
SUDs rates highest in head, neck, and gastric cancer survivors
Alcohol use disorder was the most common type of SUD across multiple subtypes of cancer patients.
News
Side Effects of Local Treatment for Advanced Prostate Cancer May Linger for Years
A new study compared long-term side effects in men with advanced prostate cancer who received initial local treatment with those who opted for...
News
Optimal Follow-up After Fertility-Sparing Cervical Cancer Surgery
Investigators sought to find out if follow-up could be tailored to the patient’s risk for recurrence.
Latest News
Active Surveillance for Low-Risk PCa: Sprint or Marathon?
For some men, the strategy can prove to be short-lived, perhaps 5 years or less , or a life-long approach lasting until the man dies from another...
